PEGCETACOPLAN Pharmacologic Class Indexing
- Class set ID
- b13ac8f2-1198-4c4d-b822-d6f0598f4a5d
- Version
- 1
- Effective date
- 20210517
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use SYFOVRE safely and effectively. See full prescribing information for SYFOVRE. SYFOVRE ® (pegcetacoplan injection), for intravitreal use Initial U.S. Approval: 2021 | Apellis Pharmaceuticals, Inc. | Juzen Chemical Corporation | Bachem AG | Eurofins Lancaster Laboratories, Inc. | Eurofins Advantar Laboratories, Inc. | Micro Measurement Laboratories, Inc. | West Services and Solutions LLC | Packaging Coordinators, LLC | Lifecore Biomedical LLC | Lifecore Biomedical | 20250916 | 12 |
| These highlights do not include all the information needed to use EMPAVELI safely and effectively. See full prescribing information for EMPAVELI. EMPAVELI ® (pegcetacoplan) injection, for subcutaneous use Initial U.S. Approval: 2021 | Apellis Pharmaceuticals, Inc. | Juzen Chemical Corporation | Bachem AG | Eurofins Lancaster Laboratories, LLC | Eurofins Advantar Laboratories, LLC | Bora Pharmaceuticals Injectables Inc. | Nelson Laboratories, LLC | AndersonBrecon Inc | Cenexi HSC | 20250730 | 13 |